1. Stanniocalcin Expression as a Predictor of Late Breast Cancer Recurrence
   Kristen D. Brantley et al, 2018, Cancer Epidemiology, Biomarkers & Prevention CrossRef
2. DNA methylation-regulated microRNA pathways in ovarian serous cystadenocarcinoma: A meta-analysis
   David Agustriawan et al, 2016, Computational Biology and Chemistry CrossRef
3. Hepatitis B virus X protein promotes hepatocarcinogenesis via the activation of HMGA2/STC2 signaling to counteract oxidative stress-induced cell death
   Fung-Yu Huang et al, 2022, Carcinogenesis CrossRef
4. Integrative analysis of PTEN‐related hub genes and validating drug targets for colorectal cancer
   Gang Wang et al, 2024, Precision Medical Sciences CrossRef
5. Clinical significance of high expression of stanniocalcin-2 in hepatocellular carcinoma
   Yuan Wang et al, 2019, Bioscience Reports CrossRef
6. Sp1 contributes to overexpression of stanniocalcin 2 through regulation of promoter activity in colon adenocarcinoma
   Ji-Bin Li et al, 2019, World Journal of Gastroenterology CrossRef
7. Transcriptional activation of FN1 and IL11 by HMGA2 promotes the malignant behavior of colorectal cancer
   Jingjing Wu et al, 2016, Carcinogenesis CrossRef
8. MiR-219-5p inhibits growth and metastasis of ovarian cancer cells by targeting HMGA2
   Feng Xing et al, 2018, Biological Research CrossRef
9. LncRNA NEAT1 inhibits apoptosis and autophagy of ovarian granulosa cells through miR-654/STC2-mediated MAPK signaling pathway
   Yu-xi Liu et al, 2023, Experimental Cell Research CrossRef
10. STIM-TRP Pathways and Microdomain Organization: Auxiliary Proteins of the STIM/Orai Complex
    Jonathan Pacheco et al, 2017, Store-Operated Ca²⁺ Entry (SOCE) Pathways CrossRef
11. Prognostic value of high stanniocalcin 2 expression in solid cancers
    Lixia Hu et al, 2019, Medicine CrossRef
12. Gene signature associated with benign neurofibroma transformation to malignant peripheral nerve sheath tumors
    Marta Martínez et al, 2017, PLOS ONE CrossRef
13. Identification of 17 mRNAs and a miRNA as an integrated prognostic signature for lung squamous cell carcinoma
    Jingyun Zhang et al, 2019, The Journal of Gene Medicine CrossRef
14. Organophosphate ester tri-o-cresyl phosphate interacts with estrogen receptor α in MCF-7 breast cancer cells promoting cancer growth
    Madeleine Böckers et al, 2020, Toxicology and Applied Pharmacology CrossRef
15. High mobility group A protein-2 as a tumor cancer diagnostic and prognostic marker: a systematic review and meta-analysis
    Yen Thi-Hai Pham et al, 2020, European Journal of Cancer Prevention CrossRef
16. Integrative Analysis Reveals STC2 as a Prognostic Biomarker of Laryngeal Squamous Cell Carcinoma
    Rong Zhong et al, 2023, Applied Biochemistry and Biotechnology CrossRef
17. 40 YEARS OF IGF1: PAPP-A and cancer
    Cheryl A Conover et al, 2018, Journal of Molecular Endocrinology CrossRef
18. Stanniocalcin 2 expression is associated with a favourable outcome in male breast cancer
    Camilla Coulson‐Gilmer et al, 2018, The Journal of Pathology: Clinical Research CrossRef
19. The Oncogenic and Diagnostic Potential of Stanniocalcin 2 in Hepatocellular Carcinoma
    Zhixian Wu et al, 2022, Journal of Hepatocellular Carcinoma CrossRef
20. Exploration of prognostic index based on immune-related genes in patients with liver hepatocellular carcinoma
    Weidong Shi et al, 2020, Bioscience Reports CrossRef
21. Combined Efficacy of CXCL5, STC2, and CHI3L1 in the Diagnosis of Colorectal Cancer
    Hui Li et al, 2022, Journal of Oncology CrossRef
22. The significance of Stanniocalcin 2 in malignancies and mechanisms
    Shasha Li et al, 2021, Bioengineered CrossRef
23. Characterization of the Immune Infiltration Landscape and Identification of Prognostic Biomarkers for Esophageal Cancer
    Yuanmei Chen et al, 2023, Molecular Biotechnology CrossRef
24. Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target
    Shuo Qie et al, 2022, Journal of Experimental & Clinical Cancer Research CrossRef